A new drug has been approved by the US FDA that targets cancer by genetic marker. Clinical trials have shown that the drug has helped shrink tumours in some patients and it is believed that the drug can assist the body’s immune system to fight the cancer. The drug is not body part specific and has been approved for use across a range of cancers.  More research is being undertaken.

The FDA just approved a drug that targets cancer by genetic marker, not body parts